We aim to transform the production of high-quality plant-derived therapeutics into an integrated, national industry that spans primary producers and manufacturers. The knowledge acquired will be applicable across related industries and used to build the specialised workforce underpinning Australia’s medicinal agriculture industry. We comprise a multidisciplinary team of research and industry partners from La Trobe University, Olivia Newton-John Cancer Research Institute, The University of Melbourne, Cann Group Ltd, Hexima, PSI, SensaData, UTT BioPharma, PARC and Bioplatforms Australia.